PPA
TGTX icon

Parametric Portfolio Associates’s TG Therapeutics TGTX Stock Holding History

Parametric Portfolio Associates’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.06M Buy
111,362
+33,111
+42% +$383K ﹤0.01% 2757
2021
Q4 		$1.49M Sell
78,251
-504
-0.6% -$13.1K ﹤0.01% 2616
2021
Q3 		$2.62M Sell
78,755
-53,045
-40% -$1.64M ﹤0.01% 2280
2021
Q2 		$5.11M Sell
131,800
-15,078
-10% -$592K ﹤0.01% 1844
2021
Q1 		$7.08M Buy
146,878
+3,622
+3% +$174K ﹤0.01% 1921
2020
Q4 		$7.45M Buy
143,256
+1,990
+1% +$67.2K ﹤0.01% 1802
2020
Q3 		$3.78M Buy
141,266
+5,016
+4% +$115K ﹤0.01% 2091
2020
Q2 		$2.65M Buy
136,250
+94,139
+224% +$1.52M ﹤0.01% 2323
2020
Q1 		$414K Buy
42,111
+3,516
+9% +$44.4K ﹤0.01% 3265
2019
Q4 		$428K Buy
38,595
+18,956
+97% +$144K ﹤0.01% 3429
2019
Q3 		$110K Sell
19,639
-1,513
-7% -$10.5K ﹤0.01% 3818
2019
Q2 		$183K Buy
21,152
+6,609
+45% +$50K ﹤0.01% 3758
2019
Q1 		$117K Buy
+14,543
New +$78.6K ﹤0.01% 3799
2017
Q4 		– Sell
-85,622
Closed -$1.01M – 3942
2017
Q3 		$1.01M Buy
85,622
+146
+0.2% +$1.66K ﹤0.01% 3035
2017
Q2 		$859K Buy
85,476
+5,822
+7% +$65.2K ﹤0.01% 3066
2017
Q1 		$928K Buy
+79,654
New +$572K ﹤0.01% 2903
2016
Q1 		– Sell
-13,955
Closed -$166K – 4025
2015
Q4 		$166K Sell
13,955
-1,663
-11% -$21K ﹤0.01% 3775
2015
Q3 		$157K Sell
15,618
-18,190
-54% -$271K ﹤0.01% 3132
2015
Q2 		$561K Buy
+33,808
New +$535K ﹤0.01% 3208

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Parametric Portfolio Associates's TGTX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its TG Therapeutics (TGTX) stake by 42% in Q1 2022, buying an estimated $383K and bringing the position to 111,362 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Parametric Portfolio Associates first reported a position in TGTX in Q2 2015 and has held it in 19 quarters since. The position peaked at $7.45M in Q4 2020. 181 funds tracked by Wall St. Rank hold TGTX as of Q1 2022.

  • Parametric Portfolio Associates held 111,362 shares of TG Therapeutics worth $1.06M as of Q1 2022.
  • Parametric Portfolio Associates bought 33,111 TG Therapeutics shares in Q1 2022, an estimated $383K.
  • TG Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2757 holding.
  • Parametric Portfolio Associates first reported a position in TG Therapeutics in Q2 2015 and has held it in 19 quarters since.
  • Parametric Portfolio Associates's TG Therapeutics position peaked at $7.45M in Q4 2020.
  • 181 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.